| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Dec 2025 - 31 May 2026 | 02 Jun 2026 | 59 | 22% | 6% | 72% | 7% |
| 01 Jun 2025 - 30 Nov 2025 | 09 Dec 2025 | 73 | 9% | 5% | 86% | 7% |
| 01 Dec 2024 - 31 May 2025 | 12 Jun 2025 | 65 | 16% | 5% | 79% | 4% |
| 01 Jun 2024 - 30 Nov 2024 | 09 Dec 2024 | 64 | 11% | 6% | 83% | 1% |
| 01 Dec 2023 - 31 May 2024 | 25 Jun 2024 | 67 | 7% | 10% | 83% | 1% |
| 01 Jun 2023 - 30 Nov 2023 | 12 Dec 2023 | 65 | 6% | 8% | 86% | 1% |
| 01 Dec 2022 - 31 May 2023 | 26 Jun 2023 | 66 | 7% | 6% | 87% | 2% |
| 01 Jun 2022 - 30 Nov 2022 | 19 Dec 2022 | 65 | 9% | 8% | 83% | 2% |
| 01 Dec 2021 - 31 May 2022 | 30 Jun 2022 | 62 | 7% | 6% | 86% | 1% |
| 01 Jun 2021 - 30 Nov 2021 | 15 Dec 2021 | 63 | 8% | 19% | 73% | 1% |
| 01 Dec 2020 - 31 May 2021 | 30 Jun 2021 | 69 | 5% | 4% | 91% | 1% |
| 01 Jun 2020 - 30 Nov 2020 | 11 Jan 2021 | 68 | 6% | 5% | 89% | 4% |
| 01 Dec 2019 - 31 May 2020 | 30 Jun 2020 | 68 | 4% | 10% | 84% | 2% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
• Qualifying contracts with entities: 60 days or the next payment run thereafter • No payment terms in majority of qualifying contracts with individuals • Purchase Order terms and conditions: the later of 60 calendar days and the next processing run immediately thereafter
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
120
Pfizer offers suppliers the opportunity to check the current status of their invoices through an accounts payable portal. Suppliers can view when their invoice is due for payment on this portal. The tool is offered free of charge. In case a supplier needs to contact Pfizer accounts payable department, an email address is available on every purchase order the supplier receives. Pfizer accounts payable department aims to resolve issues as promptly as possible, on average between 3 to 5 working days.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Pfizer R&D UK Limited is a private limited company registered in Sandwich, Kent, and incorporated in 2018. Companies House records its nature of business as other research and experimental development on natural sciences and engineering. The entity forms part of the wider Pfizer group, with its registered office at the group's long-standing Sandwich research site. As a subsidiary within the group's corporate structure, it undertakes scientific research and development activity on behalf of the wider Pfizer organisation rather than independently manufacturing or selling products. The company files full annual accounts and confirmation statements with Companies House and remains an active registered entity.
Generated from the company's website and Companies House records. Sources: find-and-update.company-information.service.gov.uk